Oncology
Taking Cancer On through Leading Science
At Boehringer Ingelheim, we are leading scientific discoveries in cancer cell agents, immuno-oncology therapies and their combinations. Together we can – and will – accelerate the delivery of the next 'first' to patients in need. Together with our global family of partners, we are taking cancer on for patients around the world.
Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right.
-
-
-
Innovation in Medicinal Chemistry: Unlocking Unsolved Diseases
Science Stories
From AI to PROTACs, Darryl McConnell and Jürgen Mack explain how our teams leverage cutting-edge approaches aiming to bring ‘undruggable’ targets within reach.
-
Cancer's Big 4: Drugging the undruggable
-
Investing in the next wave of Immuno-oncology